Our digital therapeutics combine elements of neuroscience, lifestyle medicine, and artificial intelligence to create a new modality for treating the behaviors at the root cause of cardiometabolic diseases. The approach is consistent with the latest clinical guidelines for treating diabetes, high blood pressure, and high cholesterol. Effectiveness has been demonstrated through multiple peer-reviewed and published clinical studies.
